Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
China and India have huge population issues to deal with. I dont see an infamous deed being attributed to the advancement of women's health (which could result in better reproduction) in those areas...even if there is a demand. Imo, that's not our market.
Isn't that a 3 to 4 step process? ADXS shaved off weeks of a multiple month long process. Such idiots, right? or maybe they are increasing efficiency/profit potential!
Isn"t that a 3 to 4 step process? ADXS shaved off weeks of a multiple month long process. Such idiots, right? or maybe they are increasing efficiency/profit potential!
Very cool, thanks gold007
I see it happening similar to the end of the movie 'Training Day" where Denzel goes off and proclaims to his peons " I am King Kong aint nobody got shyte on me" (to the same level but in the corporate world and down played just a bit ). Same ending though
Advaxis, Inc. (NASDAQ:ADXS) Among Today’s Most Volatile Stocks – Up $0.30
Advaxis, Inc. (NASDAQ:ADXS) last traded at $4.48 with shares having a low of $4.18 and high of $4.55. The change qualifies the stock as one of the most volatile of the day.
The $4.18 is the stock’s 52 week low. It is among the market’s biggest gainers today. It is trading at $4.48 which is much lower than $6.19, the 50 day moving average and significantly lower than the 200 day moving average of $7.33. The 50 day moving average went down $-1.71 or -27.68% whereas the 200 day average was down by -38.91%.
Short Interest
Investors are feeling more bullish recently if you take a look at the decrease in short interest. The stock recorded a fall in short interest of -2.46% as of August 31, 2017 from the last reporting period. Short interest decreased 246,365 over that period. With short interest at 9,782,022 and short average daily volume at 315,288, the short-interest ratio is 31.0 and the short interest percentage is 0.24% as of August 31. In the last earnings report the EPS was $-2.29 and is projected to be $-2.23 for the current year with 41,065,000 shares currently outstanding. Analysts expect next quarter’s EPS to be $-0.58 and the next full year EPS is anticipated to be $-2.35.
Advaxis, Inc. (NASDAQ:ADXS) Given Buy Rating at Cantor Fitzgerald
Monday, October 2nd, 2017
How about Puma vs. Advaxis? Are they that bad arse of a company which absolutely trumps Advaxis which also in turn gives reason to our/their valuation? Just thinking out loud.
My point and my opinion is Lombardo is there to tread water until we find a new ceo because DOC F'd up big time and had to go immediately. At best, under Lombardo, we sign a EU deal and submit EMA during his tenure. Unless and unlikely he is a sleeping giant (like you are suggesting?) and pulls this company out of the gutter by some miraculous "like a boss" style....as an interim CEO?...doubt it.
Lombardo is the "interim ceo." He even said as much during the webcast.
I added 400 more today. I will pick up a few hundred more if it drops again in the 3's
Bravo Fbg!!!
I had no idea there were different classes. Thank you. Mind blown once again about what will transpire in the coming days/weeks/months.
The warrants expire October 22nd, 2018 is how i read it, iggy.
How many warrants did Adage receive?
How is one to make sense of this massive sell off months away from our petx product approval and EU partner/EMA submission?
GLTAL's... we need something of substance tomorrow!
I know, i was just trying to give you a little peace to help you sleep better at night.
Fbg, you should be at least a little bit happy. Dan's has lost a lot of money on the monthly shares he has been buying over the years. You think Lombardo is going to show the same confidence and start buying....
And how many car-t deaths has there been collectively?
James, most longs would agree that things are not adding up of late. I think it is solely because we have a new CEO backed and put in place by the BOD. Advaxis will be ran differently from here out and the confusion is that we have no idea what that direction will be because we know little about Lombardo other than what is written in his bio. You are right, something is in the works, imo its just the company is going to be ran differently from here out. I thought we would see these prices immediately after DOC was let go and was surprised the market didnt hammer us back then. Personally I am just trying to stay sane and mellow and think past this ridiculous shp/mc.
Why are you so confident Easy? List the reasons after that comment...
Link to what I think of today's price:
Great now we have u2 taking us to court.
In fairness, we would all be rich and fewer people would stop dying of cancer. 3 years ago i talked to IR and was told if DOC was presented with the same deal as Aduro, he would have turned it down. I think James would validate this comment. Subsequently the person that told me that was very shortly thereafter no longer with the company. The plan didnt work out and DOC is gone now we get Lombardo's plan. Very much trying to see the silver lining.
The price drop today is justified. Aduro "giving their product away" to JNJ years ago ( what a mistake, right?) ....and DO and the BOD are sooo smart for keeping the tech for themselves for a bigger payout down the road, lol, jokes on us. Anybody got a light bc I need to set the last 3 years on fire.
Contact Dr. Petit w/ Advaxis. I remember him being very helpful with an investor a couple years ago going through something similar. God Bless!
Or at least its a foot in the door which actually means a lot!
BMY is thirsty and a bit dehydrated of new tech.
Correct, but any owner or even GM would tell you that you don't hire employees if you don't have a job for them to do.
But it was always stated that early second half 2017 submission was the plan...which puts us at the NOW time frame which also led me to my inquiry to Heber. Did I miss postponed date?
When did they disclose EMA submission was getting pushed back to Q4? I missed that one....?
DOC is gone, he is never coming back. Why does every other post I read mention his name? Like him, love him, hate him and it still wont matter because he is GONE.
On a different topic I emailed HR last week about EMA submission timeline and if "early 2H2017" ( as stated) was still on schedule or if a more accurate timeframe could be disclosed (not verbatim) and crickets so far. A bit surprised thus far I have not received a response considering previous convo's with Heber.
After waiting so long for approval....can it be?....an approval by Aratana from USDA coming any day now?? Its a shame most "investors" (I assume) will be shocked by an an approved cancer treatment immunotherapy by Advaxis will be on the shelves to treat cancer in a matter of days/years from now. Seriously, how long before we start seeing revenue from this?
A lot of insider buys near the the 52 wk low...I will follow their lead!
Shakespeare is an "old timer" yet if a long lost memo written by him to a sweetheart was brought to surface now, it would be worth millions. Words can last a lifetime and yet are the only means to truly defile oneself. Keep writing Terry!
Touche. Maybe not but it would do wonders if you decided to go long again.
A 100% increase would only equal 350 new scripts, based on your numbers, but what would it do what for the stock price given it occurred in a short time frame?
Bourbon- http://www.lamag.com/theseen/raising-a-glass-for-farrah-fawcett/
"Truth is stranger than fiction." - phyokaiser1
Pre DOC's departure, his actions would might have presumed otherwise, ie interviews with Kathy Ireland, rubbing shoulders with Trump at the white house, pictures with former Charlies angel's, ribbon cuttings with Chrstie. Ego might be in play here and big money invested might have said enough is enough.